Medicines Containing The Active Ingredient Lisdexamfetamine Atc N06Ba12

Deadline: 31 May 2026

Germany

Ref. No.: 6409194

EMD:Ref Document

Bid Value: Ref Document

4 Days Left

Medicines Containing The Active Ingredient Lanthanum Iii Carbonate Atc V03Ae03 In The Dosage Form Chewable Tablets

Deadline: 31 May 2026

Germany

Ref. No.: 6371060

EMD:Ref Document

Bid Value: Ref Document

4 Days Left

Medicines Containing The Active Substance Guselkumab Atc L04Ac16

Deadline: 31 May 2026

Germany

Ref. No.: 6368757

EMD:Ref Document

Bid Value: Ref Document

4 Days Left

Medicines Containing The Active Substance Ustekinumab Atc L04Ac05

Deadline: 31 May 2026

Germany

Ref. No.: 6337480

EMD:Ref Document

Bid Value: Ref Document

4 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Lisdexamfetamine Atc N06Ba12 Obg For The Period 01 08 24 31 07 25 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2026

Germany

Ref. No.: 6322269

EMD:Ref Document

Bid Value: Ref Document

9 Days Left

Medicines Containing The Active Ingredient Lanthanum Iii Carbonate Atc V03Ae03 In The Dosage Form Chewable Tablets

Deadline: 31 May 2026

Germany

Ref. No.: 6321582

EMD:Ref Document

Bid Value: Ref Document

4 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 6321334

EMD:Ref Document

Bid Value: Ref Document

218 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Omalizumab Atc R03Dx05 Obo For The Period 01 08 2024 31 07 2025 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2026

Germany

Ref. No.: 6320404

EMD:Ref Document

Bid Value: Ref Document

9 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 6261602

EMD:Ref Document

Bid Value: Ref Document

218 Days Left

Open Select List For Long Acting Reversible Contraceptives

Deadline: 31 Mar 2029

Great Britain

Ref. No.: 6239083

EMD:Ref Document

Bid Value: Ref Document

1039 Days Left

Dps Property Maintenance Minor Works 2024 2028

Deadline: 31 Aug 2028

Great Britain

Ref. No.: 6238425

EMD:Ref Document

Bid Value: Ref Document

827 Days Left

Open House Contracts For Multiple Active Ingredients Active Ingredient Combinations

Deadline: 01 Jun 2026

Germany

Ref. No.: 6230074

EMD:Ref Document

Bid Value: Ref Document

5 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 6229837

EMD:Ref Document

Bid Value: Ref Document

218 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Oralair Atc Code According To Who V01Aa02

Deadline: 31 Jul 2026

Germany

Ref. No.: 6175344

EMD:Ref Document

Bid Value: Ref Document

65 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Orylmyte Atc Code According To Who V01Aa03

Deadline: 31 Jul 2026

Germany

Ref. No.: 6173952

EMD:Ref Document

Bid Value: Ref Document

65 Days Left

Discover Tenders by Access Gates Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Access Gates Sector

Filter Your Search

FREE Trial plan for all new users!